MULTI-INSTITUTIONAL STUDY TO EVALUATE DNA METHYLATION MARKERS FOR DETECTION OF PRIMARY BLADDER CANCERS IN URINE SAMPLES FROM A COHORT OF PATIENTS WITH HEMATURIA
MdxHealth: Study of Urine Samples in Patients with Hematuria (Blood in Urine)
Sponsor: MDxHealth
Enrolling: Male and Female Patients
IRB Number: AAAR1050
Contact: Research Nurse Navigator: 212-342-5162 / cancerclinicaltrials@cumc.columbia.edu
Additional Study Information: This study is being conducted to evaluate the performance of the AssureMDx test for the detection of bladder cancer in patients presenting with hematuria.
This study is closed
Investigator
Joel DeCastro, MD, MPH
Do You Qualify?
Are you willing and able to give written informed consent? Yes No
Have you had blood in your urine in the last 3 months? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder



Cancel
For more information, please contact:
Research Nurse Navigator
cancerclinicaltrials@cumc.columbia.edu
212-342-5162
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE